CASE STUDY
Overview
Managing predictors of pre-term birth to improve outcomes for women and babies
It is difficult to predict and manage pre-term births and women often have to make frequent trips to hospital to predict and assess the onset of labour, with midwives using their hands to measure cervical progress. EveryBaby have developed a handheld device which measures cervical ripening with greater accuracy than existing methods, potentially reducing the prevalence of premature birth.
Our impact
200+
new contacts acquired at Arab Health with and strong interest in future collaboration from multiple potential distribution partners
More than 20 leading distributors, market consultants, hospitals, and maternity and neonatal start-ups expressed interest in the EveryBaby innovation at Arab Health
Insights and interest: EveryBaby gained valuable insights into regulatory pathways, distribution strategies and market entry opportunities across the GCC (Gulf Cooperation Council) and Asian markets
Dabriel Choi
Chief Executive Officer, EveryBaby
“Arab Health was an incredibly valuable experience for our team. Even more importantly, the meetings arranged by Health Innovation Wessex with midwives beforehand were extraordinarily helpful. These preparations prior to attending Arab Health ensured that we were well-equipped and informed. We had never encountered so many midwives in one setting, and their straightforward feedback on what works—and what doesn’t—gave us unparalleled insights into the market. Their candid guidance helped us fine-tune our approach, enabling us to enter the market with confidence.
Thanks to this thorough preparation, Arab Health became a turning point. We forged a partnership with the largest healthcare integrator in the UAE and connected with the biggest hospitals in Saudi Arabia. These successes would not have been possible without the foundational insights we gained from our discussions with midwives and physicians. These conversations helped us understand the market’s needs and speak the language of our stakeholders, ensuring that our efforts were both well-targeted and highly effective.”
Dabriel Choi
Chief Executive Officer, EveryBaby
HIW arranged meetings with physicians and midwives allowing for highly focused and in-depth discussions to understand current practices and receive feedback on the device. This was extremely valuable in refining the business strategy and effectively shaping the direction of EveryBaby’s clinical research.
We connected the team to grant experts to enhance the success of our grant funding application and conducted an in-depth review of the submission. We also supported the innovators to participate in Arab Health, enabling EveryBaby to showcase the product to stakeholders to access the Middle Eastern market.
The innovator was able to refine their business strategy and effectively shape the direction of the clinical research.
There have been conditional offers for business with certain Arab states to include the device in the care pathway for women at certain stages of pregnancy through to labour, with the objective of reducing neonatal mortality rates.
How can we help you?
If you’d like to get in touch please
email enquiries@hiwessex.net